Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Cercek

Showing results (51-60 of 214) with videos related to

Pageof 22
Sort By:
Annals of Surgical Oncology|October 25, 2013
Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumabAndrea Cercek, Michael D'Angelica, Derek Power, et al.
CA: a Cancer Journal for Clinicians|March 6, 2020
Colorectal cancer statistics, 2020Rebecca L Siegel, Kimberly D Miller, Ann Goding Sauer, et al.
Journal of Surgical Oncology|March 2, 2023
Incomplete cytoreductive surgery for appendiceal and colorectal peritoneal carcinomatosis: Characteristics and outcomes of an overlooked groupPaolo Goffredo, Nicole Aguirre, Mostafa Mohamed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2025
Organ Preservation in Rectal Cancer: Fear of Risks Versus the Risks of FearJulio Garcia-Aguilar, Hannah Williams, Martin R Weiser, et al.
Annals of Surgical Oncology|November 19, 2013
Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent diseaseKenneth Cardona, Dino Donataccio, T Peter Kingham, et al.
Annals of Surgical Oncology|August 27, 2020
Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal OriginMohammad Adileh, Jonathan B Yuval, Henry S Walch, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancerAnya Litvak, Andrea Cercek, Neil Segal, et al.
Annals of Surgical Oncology|October 1, 2020
Correction to: Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal OriginMohammad Adileh, Jonathan B Yuval, Henry S Walch, et al.
Journal of Surgical Oncology|August 28, 2016
Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapiesAndrea Cercek, Taryn M Boucher, Jill S Gluskin, et al.
Clinical Colorectal Cancer|December 3, 2014
Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancerAndrea Cercek, Jinru Shia, Marc Gollub, et al.
Pageof 22

Showing results (51-60 of 214) with videos related to

Sort By:
Pageof 22
Annals of Surgical Oncology|October 25, 2013
Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumabAndrea Cercek, Michael D'Angelica, Derek Power, et al.
CA: a Cancer Journal for Clinicians|March 6, 2020
Colorectal cancer statistics, 2020Rebecca L Siegel, Kimberly D Miller, Ann Goding Sauer, et al.
Journal of Surgical Oncology|March 2, 2023
Incomplete cytoreductive surgery for appendiceal and colorectal peritoneal carcinomatosis: Characteristics and outcomes of an overlooked groupPaolo Goffredo, Nicole Aguirre, Mostafa Mohamed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2025
Organ Preservation in Rectal Cancer: Fear of Risks Versus the Risks of FearJulio Garcia-Aguilar, Hannah Williams, Martin R Weiser, et al.
Annals of Surgical Oncology|November 19, 2013
Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent diseaseKenneth Cardona, Dino Donataccio, T Peter Kingham, et al.
Annals of Surgical Oncology|August 27, 2020
Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal OriginMohammad Adileh, Jonathan B Yuval, Henry S Walch, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancerAnya Litvak, Andrea Cercek, Neil Segal, et al.
Annals of Surgical Oncology|October 1, 2020
Correction to: Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal OriginMohammad Adileh, Jonathan B Yuval, Henry S Walch, et al.
Journal of Surgical Oncology|August 28, 2016
Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapiesAndrea Cercek, Taryn M Boucher, Jill S Gluskin, et al.
Clinical Colorectal Cancer|December 3, 2014
Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancerAndrea Cercek, Jinru Shia, Marc Gollub, et al.
Pageof 22